NCT06834165View on ClinicalTrials.gov

Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients with Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

June 30, 2026

Conditions
Allergic Reactions
Interventions
DRUG

Neffy

Epinephrine nasal spray

DRUG

Adrenaline

Epinephrine injection

Sponsors
All Listed Sponsors
lead

ARS Pharmaceuticals, Inc.

INDUSTRY

NCT06834165 - Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients with Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy | Biotech Hunter | Biotech Hunter